ArticleAging2024
The deubiquitinating enzymes-related signature predicts the prognosis and immunotherapy response in breast cancer.
Youyuan Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it